Skip to main content

Hypoglycemia

  • Chapter
  • First Online:
Diabetes and the Brain

Part of the book series: Contemporary Diabetes ((CDI))

  • 1788 Accesses

Abstract

Hypoglycemia is a common side-effect of insulin therapy for diabetes and is the major factor that limits the maintenance of strict glycemic control. It can be caused by too much insulin, insufficient carbohydrate, or strenuous exercise.

The brain depends on a continuous supply of glucose and rapidly malfunctions if deprived. Failure to reverse the falling blood glucose allows coma to supervene. Several mechanisms have evolved to protect the brain from neuroglycopenia. Counterregulatory hormones, glucagon and epinephrine (adrenaline), are secreted while sympathoadrenal activation generates autonomic warning symptoms along with those associated with cognitive dysfunction. Responses to hypoglycemia occur at different blood glucose thresholds; they can be modified by strict glycemic control and recurrent exposure to hypoglycemia.

In type 1 diabetes the annual prevalence of severe hypoglycemia (requiring help for recovery) is 30–40% while the annual incidence varies depending on the duration of diabetes. In insulin-treated type 2 diabetes, the frequency is lower but increases with duration of insulin therapy. Nocturnal hypoglycemia is common with all insulin regimens. Severe episodes are associated with serious morbidity, causing coma, seizures, injuries, and accidents. Recurrent hypoglycemia can induce acquired syndromes, which include counterregulatory hormonal deficiencies and impaired awareness of hypoglycemia, which increase the risk of severe hypoglycemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes. Diabetes Care 2005; 28:1245–1249.

    Google Scholar 

  2. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997; 46:271–286.

    Google Scholar 

  3. Deary IJ. Symptoms of hypoglycaemia and effects on mental performance and emotions. In: Hypoglycaemia in Clinical Diabetes, (Second edition). Frier BM, Fisher M, eds. Chichester: John Wiley & Sons; 2007:25–48.

    Chapter  Google Scholar 

  4. Sommerfield AJ, Deary IJ, Frier BM. Acute hyperglycemia alters mood state and impairs cognitive performance in people with Type 2 diabetes. Diabetes Care 2004; 27:2335–2340.

    Article  PubMed  Google Scholar 

  5. Cryer PE. Glucose counterregulation in man. Diabetes 1981; 30:261–264.

    PubMed  CAS  Google Scholar 

  6. Wright R, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diab/Metab Res Revs 2008; 24:353–63.

    Article  CAS  Google Scholar 

  7. McAulay V, Deary IJ, Frier BM. Symptoms of hypoglycaemia in people with diabetes. Diabet Med 2001; 18: 690–705.

    Article  PubMed  CAS  Google Scholar 

  8. Tallroth G, Lindgren M, Stenberg G, Rosen I, Agardh CD. Neurophysiological changes during insulin-induced hypoglycaemia and in the recovery period following glucose infusion in type 1 (insulin-dependent) diabetes mellitus and in normal man. Diabetologia 1990; 33:319–323.

    Article  PubMed  CAS  Google Scholar 

  9. Lindgren M, Eckert B, Stenberg G, Agardh CD. Restitution of neurophysiological functions, performance, and subjective symptoms after moderate insulin-induced hypoglycaemia in non-diabetic men. Diabet Med 1996; 13:218–225.

    Article  PubMed  CAS  Google Scholar 

  10. Vea H, Jorde R, Sager G, Vaaler S, Sundsfjord J. Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects. Diabetologia 1992; 35:958–961.

    Article  PubMed  CAS  Google Scholar 

  11. Frier BM. Impaired awareness of hypoglycaemia. In: Hypoglycaemia in Clinical Diabetes, (Second edition). Frier BM, Fisher M, eds. Chichester: John Wiley & Sons; 2007:141–170.

    Chapter  Google Scholar 

  12. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991; 8:217–222.

    Article  PubMed  CAS  Google Scholar 

  13. Pedersen-Bjergaard U, Pramming S, Heller SR, et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004; 20:479–486.

    Article  PubMed  Google Scholar 

  14. The Diabetes Control and Complications Trial Research Group. The effect of intensive insulin treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977–986.

    Google Scholar 

  15. The EURODIAB IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994; 37:278–285.

    Google Scholar 

  16. MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 1993; 10:238–245.

    Article  PubMed  CAS  Google Scholar 

  17. ter Braak EWMT, Appelman AMMF, Van de Laak MF, Stolk RP, Van Haeften TW, Erkelens DW. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 2000; 23:1467–1471.

    Article  PubMed  Google Scholar 

  18. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and type 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50:1140–1147.

    Google Scholar 

  19. The Diabetes Control and Complications Trial Research Group. Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care 1987; 10:1–19.

    Google Scholar 

  20. Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28:2948–2961.

    Article  PubMed  Google Scholar 

  21. Abraira C, Colwell JA, Nuttall FQ, et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VACSDM): results of the feasibility trial. Diabetes Care 1995; 18:1113–1123.

    Article  PubMed  CAS  Google Scholar 

  22. Leese GP, Wang J, Broomhall J, et al. (for the DARTS/MEMO Collaboration). Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003; 26:1176–1180.

    Article  PubMed  Google Scholar 

  23. Donnelly LA, Morris AD, Frier BM, et al. (for the DARTS/MEMO Collaboration). Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 2005; 22:449–455.

    Article  Google Scholar 

  24. Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 2003; 20:1016–1021.

    Article  PubMed  CAS  Google Scholar 

  25. Hepburn DA, MacLeod KM, Pell ACH, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycaemia experienced by patients with Type 2 diabetes treated with insulin. Diabet Med 1993; 10:231–237.

    Article  PubMed  CAS  Google Scholar 

  26. Allen KV, Frier BM. Nocturnal hypoglycaemia: clinical manifestations and therapeutic strategies toward prevention. Endocrine Practice 2003; 9:530–543.

    PubMed  Google Scholar 

  27. Heller SR. Nocturnal hypoglycaemia. In: Hypoglycaemia in Clinical Diabetes, (Second edition). Frier, B.M., Fisher, M, eds. Chichester: John Wiley & Sons; 2007:83–99.

    Chapter  Google Scholar 

  28. Thorsteinsson B, Pramming S, Lauritzen T, Binder C. Frequency of daytime biochemical hypoglycaemia in insulin-treated diabetic patients: relation to daily median blood glucose concentrations. Diabet Med 1986; 3:147–151.

    Article  PubMed  CAS  Google Scholar 

  29. The DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 1991; 90:450–459.

    Google Scholar 

  30. Jones TW, Porter P, Sherwin RS, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998; 338:1657–1662.

    Article  PubMed  CAS  Google Scholar 

  31. Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B. Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Diabetologia 2003; 46:89–96.

    PubMed  CAS  Google Scholar 

  32. Zammitt NN, Geddes J, Warren RE, Marioni R, Ashby JP, Frier BM. Serum angiotensin-converting enzyme and frequency of severe hypoglycaemia in Type 1 diabetes: does a relationship exist? Diabet Med 2007; 24:449–454.

    Article  Google Scholar 

  33. Dewan S, Gillett A, Mugarza JA, Dovey TM, Halford JCG, Wilding JPH. Effects of insulin-induced hypoglycaemia on energy intake and food choice at a subsequent test meal. Diab Metab Res Revs 2004; 20:405–410.

    Article  Google Scholar 

  34. Brodows RG, Williams C, Amatruda JM. Treatment of insulin reactions in diabetics. J Am Med Assoc 1984; 252:3378–381.

    Article  CAS  Google Scholar 

  35. Slama G, Traynard PY, Desplanque N, et al. The search for an optimised treatment of hypoglycemia. Carbohydrates in tablets, solution, or gel for the correction of insulin reactions. Arch Intern Med 1990; 150:589–593.

    Article  PubMed  CAS  Google Scholar 

  36. MacCuish AC. Treatment of hypoglycaemia. In: Hypoglycaemia and Diabetes: Clinical and Physiological Aspects. Frier BM, Fisher BM, eds. London: Edward Arnold, 1993:212–221.

    Google Scholar 

  37. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2008; 360:129–139.

    Article  PubMed  Google Scholar 

  38. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. New Engl J Med 2008; 358:2545–2559.

    Google Scholar 

  39. Fisher M, Heller S. Mortality, cardiovascular morbidity and possible effects of hypoglycaemia on diabetic complications. In: Hypoglycaemia in Clinical Diabetes, (Second edition). Frier BM, Fisher M, eds. Chichester: John Wiley & Sons; 2007:265–283.

    Chapter  Google Scholar 

  40. Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet Med 1991; 8:49–58.

    Article  PubMed  CAS  Google Scholar 

  41. MacLeod KM, Hepburn DA, Deary IJ, Goodwin GM, Dougall N, Ebmeier KP, Frier BM. Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia 1994; 37:257–263.

    Article  PubMed  CAS  Google Scholar 

  42. Strachan MWJ. Frequency, causes and risk factors for hypoglycaemia in type 1 diabetes. In: Hypoglycaemia in Clinical Diabetes, (Second edition). Frier BM, Fisher M, eds. Chichester: John Wiley & Sons, 2007:49–81.

    Chapter  Google Scholar 

  43. Bjorgaas M, Sand T, Vik T, Jorde R. Quantitative EEG during controlled hypoglycaemia in diabetic and non-diabetic children. Diabet Med 1998; 15:30–37.

    Article  PubMed  CAS  Google Scholar 

  44. Bottcher J, Kunze A, Kurrat C, et al. Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke 2005; 36:e20–e22.

    Article  PubMed  CAS  Google Scholar 

  45. Cordonnier C, Oppenheim C, Lamy C, Meder JF, Mas JL. Serial diffusion and perfusion-weighted MR in transient hypoglycemia. Neurology 2005; 65:175.

    Article  PubMed  CAS  Google Scholar 

  46. Strachan MWJ, Abraha HD, Sherwood RA, Lammie GA, Deary IJ, Ewing FME, Perros, P, Frier BM. Evaluation of serum markers of neuronal damage following severe hypoglycaemia in adults with insulin-treated diabetes mellitus. Diab/Metab Res Revs 1999; 15:5–12.

    Article  CAS  Google Scholar 

  47. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999; 16:466–471.

    Article  PubMed  CAS  Google Scholar 

  48. Cryer PE. Hypoglycaemia: the limiting factor in the management of Type 1 and Type 2 diabetes. Diabetologia 2002; 45:937–948.

    Article  PubMed  CAS  Google Scholar 

  49. Gerich JE, Bolli GB. Counterregulatory failure. In: Hypoglycaemia and Diabetes: Clinical and Physiological Aspects. Frier BM, Fisher BM, eds. London: Edward Arnold; 1993:253–267.

    Google Scholar 

  50. White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV. Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. New Engl J Med 1983; 308:485–491.

    Article  PubMed  CAS  Google Scholar 

  51. Bolli GB, Tsalikian E, Haymond MW, Cryer PE, Gerich JE. Defective glucose counterregulation after subcutaneous insulin in non-insulin-dependent diabetes mellitus. J Clin Invest 1984; 73:1532–1541.

    Article  PubMed  CAS  Google Scholar 

  52. Ryder RE, Owens DR, Hayes TM, Ghatei MA, Bloom SR. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. Br Med J 1990; 301:783–787.

    Article  CAS  Google Scholar 

  53. Hepburn DA, Patrick AW, Eadington DW, Ewing DJ, Frier BM. Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabet Med 1990; 7:711–717.

    Chapter  Google Scholar 

  54. Cox D.J, Gonder-Frederick L, Polonsky W, Schlundt D, Kovatchev B, Clarke W. Blood glucose awareness training (BGAT-2). Long term benefits. Diabetes Care 2001; 24:637–642.

    Article  PubMed  CAS  Google Scholar 

  55. Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med 2008; 25:501–504.

    Article  PubMed  CAS  Google Scholar 

  56. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with impaired awareness of hypoglycemia. Diabetes Care 1994; 17:697–703.

    Article  PubMed  CAS  Google Scholar 

  57. Segel SA, Paramore DA, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002; 51:724–733.

    Article  PubMed  CAS  Google Scholar 

  58. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2004; 350:2272–2279.

    Article  CAS  Google Scholar 

  59. Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Education and Counseling 2007; 68:10–15.

    Article  PubMed  Google Scholar 

  60. Frier BM. Living with hypoglycaemia. In: Hypoglycaemia in Clinical Diabetes, (Second edition). Frier BM, Fisher M, eds. Chichester: John Wiley & Sons; 2007:309–332.

    Chapter  Google Scholar 

  61. Frier BM. How hypoglycaemia can affect the life of a person with diabetes. Diab Metab Res Revs 2008; 24:87–92.

    Article  Google Scholar 

  62. Cox DJ, Gonder-Frederick LA, Kovatchev B, Julian DM, Clarke WL. Progressive hypoglycemia’s impact on driving simulation performance. Occurrence, awareness and correction. Diabetes Care 2000; 23:163–170.

    CAS  Google Scholar 

  63. Graveling AJ, Warren RE, Frier BM. Hypoglycaemia and driving in people with insulin-treated diabetes: adherence to recommendations for avoidance. Diabet Med 2004; 21:1014–1019.

    Article  PubMed  CAS  Google Scholar 

  64. Siebenhofer A, Plank J, Berghold A, et al. Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy. Diabetologia 2004; 47:1895–1905.

    Article  PubMed  CAS  Google Scholar 

  65. Pickup JC, Sutton A.J. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008; 25:765–774.

    Article  PubMed  CAS  Google Scholar 

  66. Klonoff DC. Continuous glucose monitoring. Roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28:1231–1239.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brian M. Frier BSc (Hons), MD, FRCP (Edin), FRCP (Glas) .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Frier, B.M. (2009). Hypoglycemia. In: Biessels, G., Luchsinger, J. (eds) Diabetes and the Brain. Contemporary Diabetes. Humana Press. https://doi.org/10.1007/978-1-60327-850-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-850-8_6

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-849-2

  • Online ISBN: 978-1-60327-850-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics